课题基金 / 基金详情

Early Response to Hemorrhagic Fever-Causing Arenaviruses

Early Response to Hemorrhagic Fever-Causing Arenaviruses
对引起出血热的沙粒病毒的早期反应
批准号:
6667208
负责人:
Maria S. Salvato
金额:
$19.85万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2006-08-31

项目摘要

项目成果

Maria S. Salvato的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our application will address the need for diagnostics to identify infection with a virulent hemorrhagic fever virus, Lassa fever virus (LASV). Within hours of entering the body, pathogens elicit responses from circulating white blood cells. The pathogen's capacity to alter cellular gene expression can be monitored by analysis of cellular RNA. Our approach has been to expose a standardized culture of white blood cells to a pathogen and to monitor changes in cellular mRNA expression on gene microarrays. Preliminary studies with select agents revealed several pathogen-specific changes in gene expression. Here we propose to expand our analyses to a hemorrhagic fever-causing arenavirus, Lassa Fever virus. We will test the hypothesis that we can discriminate between a dangerous hemorrhagic fever-causing virus and closely related viruses that do not cause disease. By monitoring gene expression responses at different timepoints we will determine the earliest time at which pathogen-specific gene expression signals arise. These gene-expression changes can be validated by the analysis of RNA from human and monkey peripheral blood mononuclear cells (PBMCs), and will serve as diagnostic markers of exposure to dangerous pathogens. Sets of genes will be identified that discriminate infection with Lassa Fever virus from infection with a related avirulent arenavirus, and these genes will be used to make smaller microarrays to further streamline diagnosis. Such diagnostics would eliminate the need to wait for symptoms or for pathogen replication before identifying the pathogen. This would enable more appropriate and rapid responses to a bioterrorist attack.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Persistence and Cardiopulmonary Disease
  • 批准号:
    9098781
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2015
  • 负责人:
    Maria S. Salvato
  • 依托单位:
FcRn-targeted mucosal HIV vaccine
  • 批准号:
    8880111
  • 项目类别:
  • 资助金额:
    $74.7万
  • 财政年份:
    2012
  • 负责人:
    Maria S. Salvato
  • 依托单位:
Protection of vaccine immunity by inhibiting Fas/FasL signaling
  • 批准号:
    7944104
  • 项目类别:
  • 资助金额:
    $49.21万
  • 财政年份:
    2009
  • 负责人:
    Maria S. Salvato
  • 依托单位:
Protection of vaccine immunity by inhibiting Fas/FasL signaling
  • 批准号:
    7853033
  • 项目类别:
  • 资助金额:
    $49.28万
  • 财政年份:
    2009
  • 负责人:
    Maria S. Salvato
  • 依托单位: